Global menu

Our global pages

Close

Competition for the European Medicines Agency (The "EMA") and the European Banking Authority (The "EBA")

  • Ireland
  • General

14-08-2017

 

vThe Council of the European Union (the “Council”) announced on Tuesday 1 August 2017 that 19 countries are vying to host the EMA after Brexit, six of these are also bidding for the EBA. 

The EBA is part of the European system of financial supervision and is one of three supervisory bodies, along with the European Securities and Markets Authority (the “ESMA”) and the European Insurance and occupational Pensions Authority (the “EIOPA”). Its main task is to help write the rulebook for EU financial institutions by drafting technical standards and guidelines and it administers EU-wide bank stress tests. The EMA regulates human and animal health medicines that are marketed across the EU. 

The candidates bidding for the EMA, one of Brexit’s biggest prizes, are Amsterdam, Athens, Barcelona, Bonn, Bratislava, Brussels, Bucharest, Copenhagen, Dublin, Helsinki, Lille, Milan, Porto, Sofia, Stockholm, Valletta, Vienna, Warsaw and Zagreb.

There are eight candidates bidding for the EBA: Brussels, Dublin, Frankfurt, Paris, Prague, Luxembourg City, Vienna and Warsaw.

EU member countries had until midnight Monday 31 July 2017 to submit applications for one or both agencies to the Council. The European Commission (the “Commission”) will launch its own assessment to ascertain if the relocation criteria previously set out by the Council and Commission have been fulfilled. The Commission will present its findings to the Committee of Permanent Representatives in the European Union in OctoberThe Council of the European Union (the “Council”) announced on Tuesday 1 August 2017 that 19 countries are vying to host the EMA after Brexit, six of these are also bidding for the EBA. 
The EBA is part of the European system of financial supervision and is one of three supervisory bodies, along with the European Securities and Markets Authority (the “ESMA”) and the European Insurance and occupational Pensions Authority (the “EIOPA”). Its main task is to help write the rulebook for EU financial institutions by drafting technical standards and guidelines and it administers EU-wide bank stress tests. The EMA regulates human and animal health medicines that are marketed across the EU. 

The candidates bidding for the EMA, one of Brexit’s biggest prizes, are Amsterdam, Athens, Barcelona, Bonn, Bratislava, Brussels, Bucharest, Copenhagen, Dublin, Helsinki, Lille, Milan, Porto, Sofia, Stockholm, Valletta, Vienna, Warsaw and Zagreb.

There are eight candidates bidding for the EBA: Brussels, Dublin, Frankfurt, Paris, Prague, Luxembourg City, Vienna and Warsaw.

EU member countries had until midnight Monday 31 July 2017 to submit applications for one or both agencies to the Council. The European Commission (the “Commission”) will launch its own assessment to ascertain if the relocation criteria previously set out by the Council and Commission have been fulfilled. The Commission will present its findings to the Committee of Permanent Representatives in the European Union in October.

 

Disclaimer

This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.

< Go back

Print Friendly and PDF
Register to receive regular updates via email.